Filing Details

Accession Number:
0001525587-12-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-13 16:59:01
Reporting Period:
2012-03-12
Filing Date:
2012-03-13
Accepted Time:
2012-03-13 16:59:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1311230 Solazyme Inc SZYM Industrial Organic Chemicals (2860) 331077078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1353937 Peter Licari Solazyme, Inc.
225 Gateway Boulevard
South San Francisco CA 94080
Evp, Technology No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-12 5,500 $0.86 146,216 No 4 M Direct
Common Stock Disposition 2012-03-12 7,000 $13.75 139,216 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2012-03-12 5,500 $0.00 5,500 $0.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
77,721 2018-11-04 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2011 and amended on December 10, 2011.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.54 to $14.06, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. All shares immediately exercisable. The original option grants vests as to 1/4 of the shares on October 8, 2009 and 1/36 per month of the remainder thereafter.